INTRODUCTION
activate transcription. Since this synergy occurred in the absence of EBMs, this effect is most likely indirect. 126
Interestingly, this synergy may account in part for the strong similarity in AOP's and FOXO's transcriptional 127 programmes in vivo. Statistical modelling confirmed that the outcome of combining AOP and FOXO was 128 promoter-dependent (Supplementary Table 11 ). Hence, the presence or absence of EBMs determines 129
whether AOP functions to enhance or moderate FOXO activity on a promoter. 130
To examine if synergy and antagonism of Foxo by Aop can be observed on native promoters in vivo, 131
Foxo targets were tested for patterns of transcriptional alteration by co-induction of Aop ACT , in the above-132 described transcriptomic dataset. Overall, 55 were identified in the gut (Supplementary Table 12 Table  136 14), and genome regulation in the fat body (Supplementary Table 15 ). No synergistic effects could be 137 detected in the fat body, but they could be discerned in the gut, where co-expressing both Foxo and Aop ACT 138 led to differential expression of 1022 genes (Supplementary Table 16 ), which was not evident when either 139 TF was overexpressed alone ( Figure 1E ). GO enrichment analysis suggested that these synergistically-140 regulated genes function in translation, proteolysis and mitochrondrial regulation (Supplementary Table  141 17). Thus, transcript profiling confirmed that the two modes of AOP-FOXO interaction observed on 142 synthetic reporters can also occur in vivo. This simultaneous synergy and antagonism of AOP and FOXO 143 may explain why, while activation of each TF is sufficient to promote longevity, their co-activation does not 144 result in additive effect on lifespan 3 . 145 is presumed to occur by competition for binding sites since the two recognise the same DNA sequence 24,32-153 34 . As previously reported 24, 35, 36 , transcriptional induction by PNT P1 (a constitutively active isoform of Pnt; 154 references [37] [38] [39] ) was completely blocked by AOP ACT (Figure 2A) , suggesting that PNT inhibition may be a 155 key factor in Aop's pro-longevity effect. To evaluate this possibility in vivo, the transcriptome-wide effects of 156 co-expressing Aop ACT , Pnt P1 and Foxo in the gut and fat body were assessed. In the gut, 512 transcripts 157 appeared to be subject to the combinatorial, interactive effects of the three TFs, as were 622 in the fat body 158 (Supplementary Table 18 -19, with genes regulated by over-expressing Pnt P1 alone in Supplementary Table  159 20-21). To reveal emergent transcriptional programmes in each tissue, principal component analysis (PCA) 160 was performed over the transcripts that were differentially regulated by the varying combinations of the 161 three TFs. Remarkably, the first principal component (PC) of differentially expressed genes in the gut 162 distinguished flies by published lifespan outcomes 3 with short-lived flies expressing Pnt P1 alone or in 163 combination with Foxo at one end of the PC; long-lived flies expressing one or both Foxo and Aop ACT 164 forming a distinct group at the other end of the PC; and Aop ACT countering the effect of Pnt P1 to form an 165 intermediate group ( Figure 2B ). In the fat body, a similar grouping was apparent on the diagonal of PCs 1 166 and 2 ( Figure 2C ). To infer functional consequences of these distinct transcriptional programmes, 167 transcripts from the input set corresponding to the PCs were isolated and GO enrichment analysis 168 performed (Supplementary Tables 22-23; along with GO enrichment in full sets of differentially-expressed  169   genes: Supplementary Tables 24-25 ). This revealed a strong enrichment of genes with roles in energy 170 metabolism, whose expression was strongly correlated to the PCs (Supplementary Figure 3) . Overall, a 171 combined view of the PCA and GO analysis predicted that: (1) the Foxo-Aop-Pnt circuit regulates 172 metabolism, and (2) inhibiting Pnt's output promotes longevity.and TAG were normalised to body mass. Protein density was increased by Foxo overexpression, and this 179 effect was enhanced by Pnt co-expression (Supplementary Figure 6, Supplementary Table 27) . Foxo andhad moderately increased whole-body glucose, with no evidence of alterations to TAG in this experiment 182 ( Figure 2D) . Critically, the metabolic effects of each TF were highly dependent on the activities of the 183 others for both glucose and TAG levels, as well as overall body mass, which was confirmed with statistical 184 analyses (Supplementary Tables26 and 28-29). Overall, metabolite profiling revealed a tripartite dialogue 185 between the three TFs, in which distinct combinations have unique outcomes on metabolism, hence 186 confirming the physiological prediction from the transcriptomic analysis. 187
Since Pnt appeared to dictate the transcriptional outcomes that predicted metabolic regulation by 188
the Foxo-Aop-Pnt circuit, the role of Pnt in responses to nutritional stress was further evaluated. TAG was 189 quantified after a week of Pnt over-expression, and then after a subsequent six days of starvation. sugar, increasing median survival time by 26%, despite having no effect on the low-sugar diet ( Figure 2H ). 203
Note that in two of three experiments performed, and consistent with published data 3 and fat body with S1106 extended lifespan ( Figure 3A) . Furthermore, both heterozygous and homozygous 230 mutants of Ets21C (bearing Ets21C f03639 , henceforth Ets21C F , an intronic P-element insertion which was 231 backcrossed 10 times into wild-type flies) were also long-lived relative to controls ( Figure 3B ). Thus, 232 lifespan limitation is conserved between Pnt and Ets21c. 233
Are Ets21c and Pnt relevant to lifespan in the same tissues? To target a subset of the gut and fat 234 body cells marked by S1106, both TFs were knocked down specifically in enterocytes using the inducible, 235 enterocyte-specific driver GS5966. Pnt knockdown in enterocytes alone was still sufficient to extend 236 lifespan ( Figure 3C ). However, expressing Ets21c RNAi with the same driver had no effect on longevity in 237 these cells ( Figure 3D ). This specificity appeared to reflect tissue-specific lifespan-limiting function of Pnt, 238 rather than differences in expression, since Ets21c is more highly expressed in these cells than Pnt 45 , 239 therefore suggesting a level of tissue specificity in ETS TFs' effects on ageing. In this case, knocking down 240 diverse ETS factors in diverse tissues might be expected to extend lifespan. 241
Pnt is of known relevance to neurophysiology 46 , especially in neurogenesis, and its continued 242 expression in adults 5 suggests an ongoing physiologically-relevant role in neurons. However, expressingmight be relevant to lifespan in neurons, Eip74EF was targeted by neuronal RNAi, because it is more 245 highly expressed in adult brain than in any other tissue (Supplementary Figure 7) . We found that this 246 intervention also extended lifespan ( Figure 3F ). Hence, the Drosophila ETS family includes at least fourThe ETS TFs act downstream of receptor tyrosine kinase pathways 13, 44 . We also found some 250 evidence that different RTKs limit longevity in different cells: inducing the dominant-negative form of the 251 epidermal growth factor receptor (EGFR DN ) in enterocytes extended lifespan ( Figure 3G ), phenocopying 252 knockdown of Pnt, whereas the induction of the dominant-negative insulin receptor (InR DN ) did not ( Figure  253 3H), whilst it is known to extend lifespan under control of other drivers 10 , and even though it is the more 254 highly expressed of the two RTKs in these cells 45 The apparent lifespan-limiting role of ETS factors in adult animals is doubtlessly balanced by 276 selection for their important roles in development 24 . There are at least two possible explanations for why 277 these TFs with detrimental long-term effects are active in adult tissues. ETS TF activity may simply run-on 278 from development, which may be neutral during the reproductive period (i.e. when exposed to selection) 279 but costly in the long term in aged animals. Additionally or alternatively, there may be context-dependent 280 benefits of activating transcription from the ETS site. This latter explanation is supported by two lines of 281 evidence: the enrichment of metabolic functions in the Pnt and Aop regulons suggests that metabolic 282 homeostasis is determined not by either TF alone, but by the balance of activation versus repression of 283 transcription from the ETS site, in which case benefits of Pnt activity would only be exposed in the face of 284 metabolic variation or stress. Fully consistent with the notion of context-dependent benefits of activating 285 transcription from the ETS site, the present data show that whilst Pnt is costly on a low-sugar diet, it can 286 improve survival on a high-sugar diet. The second line of evidence for context-dependent benefits of Pnt is 287 that, in mammals, different ETS TFs have distinct but partially-overlapping binding profiles 16, 19 , which may 288 indicate a shared set of core functions -perhaps in metabolism -which are important in response to 289 distinct signalling cues. In this case, the outcome of activating an ETS TF would depend on the fit between 290 promoter architecture and domains on the TF protein adjacent to the ETS domain. Indeed, the unexpected 291 recent finding that neuronal Pnt and Aop can have positively-correlated transcriptomic effects 47 is 292 consistent with highly context-dependent ETS TF function, likely subject to complex interactions of 293 euchromatin availability, a given TF's complement of protein domains, and the status of intracellular 294 signalling networks. This context-dependence makes it all the more remarkable that roles in lifespan 295 appear to be a conserved feature of the ETS TFs in diverse contexts. 296
Tissue environment appears to be a key contextual factor determining the effects of ETS TFs on 297
lifespan. This study shows that inhibiting distinct ETS TFs in multiple tissues is sufficient to extend lifespan. 298
Differences between tissues in chromatin architecture are likely to alter the capacity of a given ETS TF to 299 bind a given site. Indeed, whilst Pnt is of known neurophysiological importance, the lifespan extension 300 mediated by expressing RNAi against Pnt in the gut and fat body was not recapitulated by expressing the 301 same construct in neurons. By contrast, neuronal RNAi against Eip74EF was sufficient to extend lifespan, 302
and it has previously been implicated as a mediator of age-dependent functional decline 48 . Similar tissue-303 specific effects were evident in the matrix of Pnt and Ets21c knockdown in the gut and fat body versus the 304 gut alone. Furthermore, overexpression of dominant-negative receptor tyrosine kinases which are known to 305 act upstream of ETS TFs also had tissue-specific effects: over-expressing dominant-negative EGFR DN The structure of molecular networks and their integration amongst tissues underpins phenotype, 317 including into old age. This should be a key therapeutic consideration, as we attempt to bridge the gap 318 between genotype and specific age-related pathologies, such as dementia or cancer. Thus, unravelling the 319 basics of these networks is a critical step in identifying precise anti-ageing molecular targets 1 . Perturbing 320 specific regulatory hubs can identify potential therapeutic targets, and identifying the least disruptiveoutcomes without undesirable tradeoffs that may ensue from broader-scale perturbation. This targeting can 323 be at the level of specific proteins, specific cell types, specific points in the lifecourse, or a combination of 324 all three. The tissue-specific expression pattern of ETS TFs, and the apparent conservation of their roles in 325 longevity across distinct tissues, ETS family members and animal phyla, highlights them as important 326 regulators of tissue-specific programs, which may be beneficial in medically targeting both lifespan and 327 precise senescent pathologies. 328 mutation and maintained at large population size since original domestication. All transgenes 332 (Supplementary Table 33 ) were backcrossed into this background at least 6 times prior to experimentation 333 and maintained without bottlenecking. Cultures were maintained on 10% yeast (MP Biomedicals, OH, 334 USA), 5% sucrose (Tate & Lyle, UK), 1.5% agar (Sigma-Aldrich, Dorset, UK), 3% nipagin (Chemlink 335 Specialities, Dorset, UK), and 3% propionic acid (Sigma-Aldrich, Dorset, UK), at a constant 25 o C and 60% 336 humidity, on a 12:12 light cycle. Experimental flies were collected as embryos following 18h egg laying on 337 grape juice agar, cultured at standardised density until adulthood, and allowed to mate for 48h before 338 males were discarded and females assigned to experimental treatments at a density of 15 females/vial. To 339 induce transgene expression using the GeneSwitch system, the inducer RU486 (Sigma M8046) was 340 dissolved in absolute ethanol and added to the base medium to a final concentration of 200 µM. Ethanol 341 was added as a vehicle control to RU-negative food. For lifespan experiments, flies were transferred to 342 fresh food and survival was scored thrice weekly. Feeding RU486 to driver-only controls did not affect 343 lifespan (Supplementary Figure 8) . For starvation stress experiments, flies were fed RU486 or EtOH-344 supplemented media for one week, before switching to 1% agarose with the equivalent addition of RU486 or 345 EtOH, with death scored daily until the end. For sugar stress experiments, sugar content was increased to 346 40% w/v sucrose [40] [41] [42] . 
Molecular cloning 355
The pGL3Basic-4xFRE-pADH-Luc construct (called pGL4xFRE) described in reference 31 
